Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 395

1.

Laboratory Evaluation of a Novel Lethal Ovitrap for Control of Aedes aegypti.

Parker CN, Pereira RM, Baldwin RW, Chaskopoulou A, Koehler PG.

J Med Entomol. 2017 Nov 7;54(6):1666-1673. doi: 10.1093/jme/tjx161.

PMID:
28968892
2.

Behavioral Responses of Nymph and Adult Cimex lectularius (Hemiptera: Cimicidae) to Colored Harborages.

McNeill CA, Pereira RM, Koehler PG, McNeill SA, Baldwin RW.

J Med Entomol. 2016 Jul;53(4):760-769. Epub 2016 Apr 25.

PMID:
27113099
3.

Toxicity of fatty acid salts to German and American cockroaches.

Baldwin RW, Koehler PG, Pereira RM.

J Econ Entomol. 2008 Aug;101(4):1384-8.

PMID:
18767751
4.

Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991.

Baldwin RW, Clegg JA, Curran AC, Austin EB, Khan T, Ma Y, Gunn B, Hudecz F, Byers VS, Lepoittevin JP, Price MR.

Arch Dermatol Res. 1999 Dec;291(12):652-8.

PMID:
10651166
5.

Measurement of murine IgE antibody responses to dust mite allergens by in vitro assay.

Ma Y, Gunn B, Byers VS, Baldwin RW, Price MR.

Int J Mol Med. 1999 Jun;3(6):621-4.

PMID:
10341293
6.

A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents.

Byers VS, Levin AS, Malvino A, Waites L, Robins RA, Baldwin RW.

AIDS Res Hum Retroviruses. 1994 Apr;10(4):413-20.

PMID:
7915124
7.

Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodies.

Byers VS, Austin EB, Clegg JA, Denton G, Gunn B, Hooi D, Hudecz F, Price MR, Baldwin RW.

J Clin Immunol. 1993 Nov;13(6):406-14.

PMID:
7507127
8.

Synthesis of 2'-deoxyuridine and 5-fluoro-2'-deoxyuridine derivatives and evaluation in antibody targeting studies.

Henn TF, Garnett MC, Chhabra SR, Bycroft BW, Baldwin RW.

J Med Chem. 1993 May 28;36(11):1570-9.

PMID:
8496926
9.

Influence of carrier on biodistribution and in vitro cytotoxicity of methotrexate-branched polypeptide conjugates.

Hudecz F, Clegg JA, Kajtár J, Embleton MJ, Pimm MV, Szekerke M, Baldwin RW.

Bioconjug Chem. 1993 Jan-Feb;4(1):25-33.

PMID:
8431509
10.

Targeted kill: from umbrellas to monoclonal antibodies.

Byers VS, Baldwin RW.

J Clin Immunol. 1992 Nov;12(6):391-405. Review. No abstract available.

PMID:
1287032
12.

An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours.

Durrant LG, Denton GW, Jacobs E, Mee M, Moss R, Austin EB, Baldwin RW, Hardcastle JD, Robins RA.

Int J Cancer. 1992 Mar 12;50(5):811-6.

PMID:
1544714
13.

Synthesis, conformation, biodistribution, and in vitro cytotoxicity of daunomycin-branched polypeptide conjugates.

Hudecz F, Clegg JA, Kajtár J, Embleton MJ, Szekerke M, Baldwin RW.

Bioconjug Chem. 1992 Jan-Feb;3(1):49-57.

PMID:
1616949
15.

Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.

Robins RA, Denton GW, Hardcastle JD, Austin EB, Baldwin RW, Durrant LG.

Cancer Res. 1991 Oct 1;51(19):5425-9.

16.

Induction of delayed hypersensitivity to human tumor cells with a human monoclonal anti-idiotypic antibody.

Austin EB, Robins RA, Baldwin RW, Durrant LG.

J Natl Cancer Inst. 1991 Sep 4;83(17):1245-8.

PMID:
1870151
18.

Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action.

Byers VS, Pawluczyk IZ, Hooi DS, Price MR, Carroll S, Embleton MJ, Garnett MC, Berry N, Robins RA, Baldwin RW.

Cancer Res. 1991 Apr 15;51(8):1990-5.

19.

Rationale for clinical use of immunotoxins in cancer and autoimmune disease.

Byers VS, Baldwin RW.

Semin Cell Biol. 1991 Feb;2(1):59-70. Review.

PMID:
1954344
20.

Monoclonal antibodies: new agents for cancer detection and targeted therapy.

Baldwin RW, Byers VS.

Cancer Detect Prev. 1991;15(2):133-6.

PMID:
2032254
22.

Reactivity of an anti-(human gastric carcinoma) monoclonal antibody with core-related peptides of gastrointestinal mucin.

Price MR, Sekowski M, Yang GY, Durrant LG, Robins RA, Baldwin RW.

Cancer Immunol Immunother. 1991;33(2):80-4.

PMID:
1709822
23.

A phase I/II study of trichosanthin treatment of HIV disease.

Byers VS, Levin AS, Waites LA, Starrett BA, Mayer RA, Clegg JA, Price MR, Robins RA, Delaney M, Baldwin RW.

AIDS. 1990 Dec;4(12):1189-96.

PMID:
2128454
24.

Carrier design: biodistribution of branched polypeptides with a poly(L-lysine) backbone.

Clegg JA, Hudecz F, Mezö G, Pimm MV, Szekerke M, Baldwin RW.

Bioconjug Chem. 1990 Nov-Dec;1(6):425-30.

PMID:
2099188
25.
26.

Bispecific antibody that binds carcinoembryonic antigen and ricin toxin A chain cytotoxic for gastrointestinal tract tumor cells.

Robins RA, Embleton MJ, Pimm MV, Betts DS, Charleston A, Markham AJ, Baldwin RW.

J Natl Cancer Inst. 1990 Aug 1;82(15):1295-6. No abstract available.

PMID:
2374178
27.

Immunological and structural features of the protein core of human polymorphic epithelial mucin.

Price MR, Hudecz F, O'Sullivan C, Baldwin RW, Edwards PM, Tendler SJ.

Mol Immunol. 1990 Aug;27(8):795-802.

PMID:
1698259
28.
30.

Immunoconjugate design: a predictive approach for coupling of daunomycin to monoclonal antibodies.

Hudecz F, Ross H, Price MR, Baldwin RW.

Bioconjug Chem. 1990 May-Jun;1(3):197-204.

PMID:
2096913
31.

C595--a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas.

Price MR, Pugh JA, Hudecz F, Griffiths W, Jacobs E, Symonds IM, Clarke AJ, Chan WC, Baldwin RW.

Br J Cancer. 1990 May;61(5):681-6.

32.

A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.

Pimm MV, Robins RA, Embleton MJ, Jacobs E, Markham AJ, Charleston A, Baldwin RW.

Br J Cancer. 1990 Apr;61(4):508-13.

33.

Detection of polymorphic epithelial mucins in the serum of systemic breast cancer patients using the monoclonal antibody, NCRC-11.

Price MR, Clarke AJ, Robertson JF, O'Sullivan C, Baldwin RW, Blamey RW.

Cancer Immunol Immunother. 1990;31(5):269-72.

PMID:
2376045
34.
35.
36.

Production of a human monoclonal antibody recognising a determinant on mouse IgG2b from a patient receiving mouse monoclonal antibody for diagnostic imaging.

Durrant LG, Robins RA, Ballantyne KC, Austin EB, Baldwin RW.

Cancer Immunol Immunother. 1990;31(4):226-30.

PMID:
1696174
37.

Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.

Durrant LG, Robins RA, Ballantyne KC, Marksman RA, Hardcastle JD, Baldwin RW.

Br J Cancer. 1989 Dec;60(6):855-60.

38.

Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.

Byers VS, Rodvien R, Grant K, Durrant LG, Hudson KH, Baldwin RW, Scannon PJ.

Cancer Res. 1989 Nov 1;49(21):6153-60.

39.

Development of an ELISA to detect early local relapse of colorectal cancer.

Durrant LG, Jones H, Armitage NC, Baldwin RW.

Br J Cancer. 1989 Oct;60(4):533-7.

42.

Intraperitoneal 131I- and 111In-791T/36 monoclonal antibody in recurrent ovarian cancer: imaging and biodistribution.

Perkins AC, Pimm MV, Gie C, Marksman RA, Symonds EM, Baldwin RW.

Nucl Med Commun. 1989 Aug;10(8):577-84.

PMID:
2812640
43.

Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36.

Austin EB, Robins RA, Durrant LG, Price MR, Baldwin RW.

Immunology. 1989 Aug;67(4):525-30.

44.

Carrier presentation: a possible strategy for selective in vivo amplification of specific T cells.

Saxena HM, Robins RA, Baldwin RW.

Med Hypotheses. 1989 Aug;29(4):255-9.

PMID:
2586351
45.

Mouse IgG2b monoclonal antibody fragmentation. Preparation and purification of Fab, Fc and Fab/c fragments.

Demignot S, Garnett MC, Baldwin RW.

J Immunol Methods. 1989 Jul 26;121(2):209-17.

PMID:
2503561
46.

Monoclonal antibody immunoconjugates for cancer treatment.

Baldwin RW, Byers VS.

Curr Opin Immunol. 1989 Jun;1(5):891-4. Review. No abstract available.

PMID:
2679735
47.

Discrimination between normal and malignant hepatocytes in man by the monoclonal antibody RL23/36: comparison with the Ca1 and 791T/36 monoclonal antibodies.

Hawkey CJ, Holmes CH, Chainuvatti T, Viranuvatti V, Smith PG, Toghill PJ, Baldwin RW.

Asian Pac J Allergy Immunol. 1989 Jun;7(1):51-5.

PMID:
2473760
48.

Flow cytometric screening of monoclonal antibodies for drug or toxin targeting to human cancer.

Durrant LG, Robins RA, Baldwin RW.

J Natl Cancer Inst. 1989 May 3;81(9):688-96.

PMID:
2468779
49.

Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.

Durrant LG, Byers VS, Scannon PJ, Rodvien R, Grant K, Robins RA, Marksman RA, Baldwin RW.

Clin Exp Immunol. 1989 Feb;75(2):258-64.

50.

Supplemental Content

Loading ...
Support Center